A new cancer diagnostic test is set to be trialled in Surrey and Sussex following PinPoint Data Science’s success in securing SBRI Healthcare funding.
PinPoint’s artificial intelligence cancer detection test allows clinicians to ‘red flag’ high-risk patients and has been validated in retrospective assessments of 147,000 patients.
This latest funding will see the technology being rolled-out across other areas in England with support from the Academic Health Science Network (AHSN), Kent Surrey Sussex AHSN and the Innovation Agency.
Commenting on the news, Keri Torney, Managing Director for Surrey and Sussex Cancer Alliance, said: "We are pleased to be working with PinPoint to support the trialling of this technology which aims to improve outcomes for patients across our footprint."
Read more on this story here on the Kent Surrey Sussex AHSN website.